PROTAGONIST THERAPEUTICS INC's ticker is PTGX and the CUSIP is 74366E102. A total of 145 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.11 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $411 | -100.0% | 14,895 | -77.7% | 0.00% | -100.0% |
| Q3 2020 | $1,308,000 | -12.3% | 66,928 | -20.7% | 0.00% | -33.3% |
| Q2 2020 | $1,491,000 | +957.4% | 84,417 | +322.1% | 0.00% | – |
| Q4 2019 | $141,000 | -26.6% | 20,000 | -30.1% | 0.00% | -100.0% |
| Q4 2018 | $192,000 | -79.7% | 28,602 | -68.9% | 0.00% | -50.0% |
| Q3 2018 | $947,000 | +69.1% | 92,041 | +10.4% | 0.00% | +100.0% |
| Q2 2018 | $560,000 | – | 83,341 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 2,449,183 | $43,400,000 | 3.81% |
| BVF INC/IL | 3,901,759 | $69,139,000 | 2.70% |
| COMMODORE CAPITAL LP | 498,079 | $8,826,000 | 2.33% |
| Altium Capital Management LP | 346,000 | $6,131,000 | 1.61% |
| Twin Lakes Capital Management, LLC | 139,287 | $2,468,000 | 1.45% |
| Opaleye Management Inc. | 330,222 | $5,852,000 | 1.09% |
| EcoR1 Capital, LLC | 1,443,800 | $25,584,000 | 0.89% |
| OBERMEYER WOOD INVESTMENT COUNSEL, LLLP | 776,689 | $13,763,000 | 0.76% |
| JABODON PT CO | 90,656 | $1,606,000 | 0.66% |
| Artal Group S.A. | 1,500,000 | $26,580,000 | 0.60% |